Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,362 public trials 335 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

NCT07190248

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Central Alabama Research ( Site 0108) Birmingham, Alabama, United States
  • Stamford Hospital ( Site 0126) Stamford, Connecticut, United States
  • Mount Sinai Cancer Center ( Site 0137) Miami Beach, Florida, United States
  • New England Cancer Specialists ( Site 0139) Westbrook, Maine, United States
View all 212 locations
View Trial Details
Recruiting

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

NCT07431827

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Instituto Alexander Fleming ( Site 0310) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Sanatorio Parque ( Site 0311) Rosario, Santa Fe Province, Argentina
  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0306) CABA, Argentina
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0309) CABA, Argentina
View all 106 locations
View Trial Details
Recruiting

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

NCT07554339

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • NHO Revive Research Institute LLC ( Site 0118) Lincoln, Nebraska, United States
  • New York Oncology Hematology P.C ( Site 9000) Albany, New York, United States
  • Clinica Adventista Belgrano ( Site 0304) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0303) Mar del Plata, Buenos Aires, Argentina
View all 80 locations
View Trial Details
Recruiting

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

NCT06745882

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • TidalHealth Peninsula Regional Salisbury, Maryland, United States
  • Montefiore Medical Cancer Center The Bronx, New York, United States
View Trial Details
Recruiting

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

NCT07629960

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • Next Oncology Virginia Cancer Specialist Fairfax, Virginia, United States
  • Florida Cancer Specialists & Research Institute - Sarasota Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mary Bird Perkins Cancer Center Baton Rouge, Louisiana, United States
View all 16 locations
View Trial Details
Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT06767514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Study Site Chandler, Arizona, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Hot Springs, Arkansas, United States
  • Clinical Study Sites Jonesboro, Arkansas, United States
View all 285 locations
View Trial Details
Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations
  • Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States
  • Washington University St Louis, Missouri, United States
View all 17 locations
View Trial Details
Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

NCT06692738

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Beverly Hills, California, United States
View all 328 locations
View Trial Details
Recruiting

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

NCT07513376

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Smilow Cancer Center at Yale-New Haven ( Site 3253) New Haven, Connecticut, United States
  • Billings Clinic ( Site 3255) Billings, Montana, United States
  • NHO Revive Research Institute, LLC ( Site 3218) Lincoln, Nebraska, United States
  • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 3207) Reno, Nevada, United States
View all 93 locations
View Trial Details

Related conditions